ReproCELL Inc.

In News

REPROCELL Launches StemEdit - Clinical Gene Editing Services and New iPSC Lines Using AI-Designed editing tools - BioSpace

BioSpace - Jan 29, 2026

REPROCELL Launches GMP Master Cell Bank Manufacturing for Clinical iPSCs - PR Newswire

PR Newswire - Mar 03, 2026

Stem Cell Stories: More Than Just Labs - theworldfolio.com

theworldfolio.com - Oct 11, 2025

REPROCELL announces US FDA drug master file submittal for StemRNA™ clinical iPSC seed clones - drugdiscoverynews.com

drugdiscoverynews.com - Jul 30, 2025

REPROCELL USA Receives Funding from the Maryland Stem Cell Research Fund (MSCRF) - Yahoo Finance

Yahoo Finance - Oct 22, 2025

GMP Manufacturing of iPSC Master Cell Banks for Allogeneic Therapies at REPROCELL: A Cost-Optimized Approach - bioinformant.com

bioinformant.com - Dec 20, 2025

ReproCELL Stock Hits Day Low at JPY 174 Amid Price Pressure - marketsmojo.com

marketsmojo.com - Mar 10, 2026

Governor Moore Meets with Japan’s Chief Cabinet Secretary, Renews Memorandum of Understanding with Kanagawa Prefecture - Office of Governor Wes Moore (.gov)

Office of Governor Wes Moore (.gov) - Apr 15, 2025

REPROCELL’s StemRNA™ iPSC Seed Stock Clones for Seamless Translational Research - bioinformant.com

bioinformant.com - Aug 04, 2025

Reprocell reports mixed results for phase II Stemchymal trial in spinocerebellar ataxia - bioworld.com

bioworld.com - May 30, 2023

Maryland Stem Cell Research Fund Awards $4.7 million to Support Innovations in Stem Cell Research - PR Newswire

PR Newswire - Oct 02, 2025

REPROCELL’s Clinical-Grade iPSCs: Advancing Cell Therapy - bioinformant.com

bioinformant.com - Mar 12, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment